Plataforma de Cannabis Medicinal y Cáñamo Industrial
Plataforma de Cannabis Medicinal y Cáñamo Industrial
AI METHODS FOR ANALYSIS AND RECOMMENDATION OF CANNABIS COMPOSITIONS
10/02/2023 -
Systems, methods, and computer program products are provided for ranking plant-based products based on consistency of formulation. In various embodiments, a method is provided where a plurality of...
BLENDED CANNABIS COMPOUNDS AND METHODS OF MAKING THE SAME
10/02/2023 -
Blended, processed marijuana and/or hemp cannabis compounds and methods of making the same are provided. In particular, the compound includes one or more species of cannabis mixed in...
MODIFIED AUTOFLOWER CANNABIS PLANTS WITH VALUE PHENOTYPES
10/02/2023 -
Provided herein are modified Cannabis plants exhibiting a modified day-length sensitivity phenotype and at least one Value Phenotype such as architecture, determinant growth, cannabinoid content,...
COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND/OR AUTISM
10/02/2023 -
Provided is a liquid cannabis composition comprising CBD and/or CBDA at a concentration in the range of from about 26wt% to about 50wt%; at least two mono- terpenes selected from the group consisting...
BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES
10/02/2023 -
Described herein are methods, compositions, products, and processes that utilize bioceramics in traditional agricultural and hydroponic systems. The bioceramics are utilized in powder form, as...
PHARMACEUTICAL PRODUCTS BASED ON CANNABINOID ACID ESTERS
10/02/2023 -
The present application relates to a method of producing cannabinoid esters directly from a selected material of a plant of the Cannabis sp. genus, preferably of Cannabis sativa with simultaneous...
METHODS FOR TREATMENT OF HUMAN CANCERS USING CANNABIS COMPOSITIONS
10/02/2023 -
Compositions and methods are provided for the treatment of a variety of human cancers. The compositions generally comprise at least one cannabinoid, or an extract of Cannabis spp. combined with at...
CANNABIS LIMITS CANCER STEM CELL GROWTH IN POORLY DIFFERENTIATED CANCERS
10/02/2023 -
The present invention provides a composition comprising a cannabinoid for inhibiting growth of cancer stem cells. This invention also provides methods of treating cancer comprising cancer stem...
CANNABIS LIMITS CANCER STEM CELL GROWTH IN POORLY DIFFERENTIATED CANCERS
10/02/2023 -
The present invention provides a composition comprising a cannabinoid for inhibiting growth of cancer stem cells. This invention also provides methods of treating cancer comprising cancer stem cells...
DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH
10/02/2023 -
The present invention discloses compositions from mushrooms and cannabis, including with synergistic and entourage enhanced combinations of psilocybin and other psychoactive tryptamines, THC, CBD,...
CRYOGENIC HOP LUPULIN OR CANNABIS TRICHOME PELLETS
10/02/2023 -
An enriched trichome pellet product including either a hop derived lupulin component or a cannabis derived trichome component, and the associated cryogenic and mechanical method for the...
Transdermal composition comprising cannabidiol (CBD) for treatment of epilepsy
06/09/2022 -
Disclosed are the preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and their use in the treatment of epilepsy. Preferably, the CBD is provided in the form of a high...
Use of cannabidiol and clobazam in the treatment of childhood-onset epilepsy syndromes
06/09/2022 -
Cannabidiol (CBD) for use in the treatment of childhood onset epilepsy in patients who are concurrently taking clobazam characterised in that the patient is monitored for incidence of pneumonia, is...
EXTRACTION, SEPARATION AND PURIFICATION OF CANNABINOIDS FROM CANNABIS STAIVA AND OTHER MARIJUANA BIOMASS
06/09/2022 -
This invention is for the improved extraction, separation, and manufacturing of pharmaceutical grade CBD, CBDA, A9-THC, M-THCA and other cannabinoids following current Good Manufacturing Practices...
Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
06/09/2022 -
A cannabidiol (CBD) preparation for use in the treatment of seizures associated with epilepsy in patients who are concurrently taking bivaracetam is provided wherein the dose of brivaracetam is...
USE OF CANNABINOIDS IN THE TREATMENT OF COMORBIDITIES ASSOCIATED WITH EPILEPSY
06/09/2022 -
The present invention relates to the use of a specific composition of cannabidiol (CBD) in the treatment of comorbidities associated with epilepsy. In one embodiment the comorbidities are...
TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF SEIZURE DISORDERS
06/09/2022 -
The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form...
PROTECTIVE HEMP OIL FOR WOOD TREATMENT METHOD
06/09/2022 -
The present invention relates to the use of cannabidivarin (CBDV) for the treatment of seizures associated with canine epilepsy. In a further embodiment the CBDV used is in the form of a highly...
COMPOSITION CONTAINING EXTRACT OF CANNABIS SATIVA FOR PREVENTING OR TREATING METABOLIC SYNDROME-RELATED DISEASE
06/09/2022 -
The present disclosure relate to a composition for preventing and treating metabolic disease containing a Cannabis sativa extract, and may provide a composition for preventing and treating...
PREPARATION AND USE OF CANNABIS NANO-FORMULATION
06/09/2022 -
The present application relates to a formulation comprising at least one natural cannabis material, at least one solvent, and at least one stabilizer, wherein the formulation is a liquid suspension...
COMPOSITIONS FOR TREATMENT OF INTERSTITIAL CYSTITIS AND OTHER BLADDER DISEASE
06/05/2022 -
Compositions and methods are provided for the treatment of interstitial cystitis and other bladder disease processes. The compositions generally comprise at least one edible or medicinal mushroom...
